Impact of direct-acting antiviral therapy on liver fibrosis regression among people with chronic hcv infection: results from a real-life cohort in patients who achieved sustained virological response

HIGHLIGHTS

• who: Alejandro Garcu00eda-Ros and colleagues from the Department of Emergency Medicine, Santa Lucu00eda University Hospital, Cartagena, Spain have published the Article: Impact of Direct-Acting Antiviral Therapy on Liver Fibrosis Regression among People with Chronic HCV Infection: Results from a Real-Life Cohort in Patients Who Achieved Sustained Virological Response, in the Journal: Medicina 2023, 814 of /2023/

SUMMARY

Of 16 Taking the baseline fibrotic stage as a reference, the distribution in the subgroups was as follows: 77 F4 patients (31.0%); 55 F3 patients (22.2%); 53 F2 patients (21.4 . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.